Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DelveInsight | PRODUCT CODE: 1506487

Cover Image

PUBLISHER: DelveInsight | PRODUCT CODE: 1506487

Autism Spectrum Disorder - Market Insight, Epidemiology, and Market Forecast - 2034

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 7950
PDF (2-3 User License)
USD 11925
PDF (Site License)
USD 15900
PDF (Global License)
USD 23850

Add to Cart

DelveInsight's "Autism Spectrum Disorder - Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Autism Spectrum Disorder, historical and forecasted epidemiology as well as the Autism Spectrum Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Autism Spectrum Disorder market report provides current treatment practices, emerging drugs, Autism Spectrum Disorder market share of the individual therapies, current and forecasted Autism Spectrum Disorder market size from 2020 to 2034 segmented by seven major markets. The Report also covers current Autism Spectrum Disorder treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Geography Covered:

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2020-2034

Autism Spectrum Disorder Disease Understanding and Treatment Algorithm

The DelveInsight Autism Spectrum Disorder market report gives a thorough understanding of the Autism Spectrum Disorder by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment.

Diagnosis

This segment of the report covers the detailed diagnostic methods or tests for Autism Spectrum Disorder.

Treatment

It covers the details of conventional and current medical therapies available in the Autism Spectrum Disorder market for the treatment of the condition. It also provides Autism Spectrum Disorder treatment algorithms and guidelines in the United States, Europe, and Japan.

Autism Spectrum Disorder Epidemiology

The Autism Spectrum Disorder epidemiology division provide insights about historical and current Autism Spectrum Disorder patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Autism Spectrum Disorder epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2020 to 2034.

Country Wise-Autism Spectrum Disorder Epidemiology

The epidemiology segment also provides the Autism Spectrum Disorder epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Autism Spectrum Disorder Drug Chapters

Drug chapter segment of the Autism Spectrum Disorder report encloses the detailed analysis of Autism Spectrum Disorder marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Autism Spectrum Disorder clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Marketed Drugs

The report provides the details of the marketed product available for Autism Spectrum Disorder treatment.

Autism Spectrum Disorder Emerging Drugs

The report provides the details of the emerging therapies under the late and mid-stage of development for Autism Spectrum Disorder treatment.

Autism Spectrum Disorder Market Outlook

The Autism Spectrum Disorder market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Autism Spectrum Disorder market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

This segment gives a thorough detail of Autism Spectrum Disorder market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, Autism Spectrum Disorder market in 7MM is expected to change in the study period 2020-2034.

Key Findings

This section includes a glimpse of the Autism Spectrum Disorder market in 7MM.

The United States Market Outlook

This section provides the total Autism Spectrum Disorder market size and market size by therapies in the United States.

EU-5 Countries: Market Outlook

The total Autism Spectrum Disorder market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.

Japan Market Outlook

The total Autism Spectrum Disorder market size and market size by therapies in Japan is also mentioned.

Autism Spectrum Disorder Drugs Uptake

This section focusses on the rate of uptake of the potential drugs recently launched in the Autism Spectrum Disorder market or expected to get launched in the market during the study period 2020-2034. The analysis covers Autism Spectrum Disorder market uptake by drugs; patient uptake by therapies; and sales of each drug.

This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Autism Spectrum Disorder Pipeline Development Activities

The report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Autism Spectrum Disorder key players involved in developing targeted therapeutics.

Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition and merger, licensing, patent details and other information for Autism Spectrum Disorder emerging therapies.

Reimbursement Scenario in Autism Spectrum Disorder

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

KOL- Views

To keep up with current market trends, we take KOLs and SME's opinion working in Autism Spectrum Disorder domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Autism Spectrum Disorder market trend. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Competitive Intelligence Analysis

We perform Competitive and Market Intelligence analysis of the Autism Spectrum Disorder Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.

Scope of the Report:

  • The report covers the descriptive overview of Autism Spectrum Disorder, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Autism Spectrum Disorder epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Autism Spectrum Disorder are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Autism Spectrum Disorder market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Autism Spectrum Disorder market

Report Highlights:

  • In the coming years, Autism Spectrum Disorder market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
  • The companies and academics are working to assess challenges and seek opportunities that could influence Autism Spectrum Disorder R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
  • Major players are involved in developing therapies for Autism Spectrum Disorder. Launch of emerging therapies will significantly impact the Autism Spectrum Disorder market
  • A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Autism Spectrum Disorder
  • Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Autism Spectrum Disorder Report Insights

  • Patient Population
  • Therapeutic Approaches
  • Autism Spectrum Disorder Pipeline Analysis
  • Autism Spectrum Disorder Market Size and Trends
  • Market Opportunities
  • Impact of upcoming Therapies

Autism Spectrum Disorder Report Key Strengths

  • 11 Years Forecast
  • 7MM Coverage
  • Autism Spectrum Disorder Epidemiology Segmentation
  • Key Cross Competition
  • Highly Analyzed Market
  • Drugs Uptake

Autism Spectrum Disorder Report Assessment

  • Current Treatment Practices
  • Unmet Needs
  • Pipeline Product Profiles
  • Market Attractiveness
  • Market Drivers and Barriers

Key Questions:

Market Insights:

  • What was the Autism Spectrum Disorder market share (%) distribution in 2020 and how it would look like in 2034?
  • What would be the Autism Spectrum Disorder total market size as well as market size by therapies across the 7MM during the forecast period (2024-2034)?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest Autism Spectrum Disorder market size during the forecast period (2024-2034)?
  • At what CAGR, the Autism Spectrum Disorder market is expected to grow in 7MM during the forecast period (2020-2034)?
  • What would be the Autism Spectrum Disorder market outlook across the 7MM during the forecast period (2020-2034)?
  • What would be the Autism Spectrum Disorder market growth till 2032, and what will be the resultant market Size in the year 2034?
  • How would the market drivers, barriers and future opportunities affect the market dynamics and subsequent analysis of the associated trends?

Epidemiology Insights:

  • What is the disease risk, burden and unmet needs of the Autism Spectrum Disorder?
  • What is the historical Autism Spectrum Disorder patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
  • What would be the forecasted patient pool of Autism Spectrum Disorder in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Autism Spectrum Disorder?
  • Out of all 7MM countries, which country would have the highest prevalent population of Autism Spectrum Disorder during the forecast period (2020-2034)?
  • At what CAGR the population is expected to grow in 7MM during the forecast period (2020-2034)?

Current Treatment Scenario, Marketed Drugs and Emerging Therapies:

  • What are the current options for the Autism Spectrum Disorder treatment, along with the approved therapy?
  • What are the current treatment guidelines for the treatment of Autism Spectrum Disorder in the USA, Europe, and Japan?
  • What are the Autism Spectrum Disorder marketed drugs and their MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
  • How many companies are developing therapies for the treatment of Autism Spectrum Disorder?
  • How many therapies are developed by each company for Autism Spectrum Disorder treatment?
  • How many are emerging therapies in mid-stage, and late stage of development for Autism Spectrum Disorder treatment?
  • What are the key collaborations (Industry - Industry, Industry - Academia), Mergers and acquisitions, licensing activities related to the Autism Spectrum Disorder therapies?
  • What are the recent novel therapies, targets, mechanisms of action and technologies developed to overcome the limitation of existing therapies?
  • What are the clinical studies going on for Autism Spectrum Disorder and their status?
  • What are the key designations that have been granted for the emerging therapies for Autism Spectrum Disorder?
  • What are the global historical and forecasted market of Autism Spectrum Disorder?

Reasons to buy:

  • The report will help in developing business strategies by understanding trends shaping and driving the Autism Spectrum Disorder market
  • To understand the future market competition in the Autism Spectrum Disorder market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Autism Spectrum Disorder in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Autism Spectrum Disorder market
  • To understand the future market competition in the Autism Spectrum Disorder market
Product Code: DIMI0481

Table of Contents

1. Key Insights

2. Executive Summary of Autism Spectrum Disorder

3. Competitive Intelligence Analysis for Autism Spectrum Disorder

4. Autism Spectrum Disorder: Market Overview at a Glance

  • 4.1. Autism Spectrum Disorder Total Market Share (%) Distribution in 2020
  • 4.2. Autism Spectrum Disorder Total Market Share (%) Distribution in 2034

5. Autism Spectrum Disorder: Disease Background and Overview

  • 5.1. Introduction
  • 5.2. Sign and Symptoms
  • 5.3. Pathophysiology
  • 5.4. Risk Factors
  • 5.5. Diagnosis

6. Patient Journey

7. Autism Spectrum Disorder Epidemiology and Patient Population

  • 7.1. Epidemiology Key Findings
  • 7.2. Assumptions and Rationale: 7MM
  • 7.3. Epidemiology Scenario: 7MM
    • 7.3.1. Autism Spectrum Disorder Epidemiology Scenario in the 7MM (2020-2034)
  • 7.4. United States Epidemiology
    • 7.4.1. Autism Spectrum Disorder Epidemiology Scenario in the United States (2020-2034)
  • 7.5. EU-5 Country-wise Epidemiology
    • 7.5.1. Germany Epidemiology
      • 7.5.1.1. Autism Spectrum Disorder Epidemiology Scenario in Germany (2020-2034)
    • 7.5.2. France Epidemiology
      • 7.5.2.1. Autism Spectrum Disorder Epidemiology Scenario in France (2020-2034)
    • 7.5.3. Italy Epidemiology
      • 7.5.3.1. Autism Spectrum Disorder Epidemiology Scenario in Italy (2020-2034)
    • 7.5.4. Spain Epidemiology
      • 7.5.4.1. Autism Spectrum Disorder Epidemiology Scenario in Spain (2020-2034)
    • 7.5.5. United Kingdom Epidemiology
      • 7.5.5.1. Autism Spectrum Disorder Epidemiology Scenario in the United Kingdom (2020-2034)
    • 7.5.6. Japan Epidemiology
      • 7.5.6.1. Autism Spectrum Disorder Epidemiology Scenario in Japan (2020-2034)

8. Treatment Algorithm, Current Treatment, and Medical Practices

  • 8.1. Autism Spectrum Disorder Treatment and Management
  • 8.2. Autism Spectrum Disorder Treatment Algorithm

9. Unmet Needs

10. Key Endpoints of Autism Spectrum Disorder Treatment

11. Marketed Products

  • 11.1. List of Marketed Products in the 7MM
  • 11.2. Drug Name: Company Name
    • 11.2.1. Product Description
    • 11.2.2. Regulatory Milestones
    • 11.2.3. Other Developmental Activities
    • 11.2.4. Pivotal Clinical Trials
    • 11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

  • 12.1. Key Cross
  • 12.2. Drug Name: Company Name
    • 12.2.1. Product Description
    • 12.2.2. Other Developmental Activities
    • 12.2.3. Clinical Development
    • 12.2.4. Safety and Efficacy
    • 12.2.5. Product Profile

List to be continued in report

13. Autism Spectrum Disorder: Seven Major Market Analysis

  • 13.1. Key Findings
  • 13.2. Autism Spectrum Disorder Market Size in 7MM
  • 13.3. Autism Spectrum Disorder Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

  • 15.1. United States: Market Size
    • 15.1.1. Autism Spectrum Disorder Total Market Size in the United States
    • 15.1.2. Autism Spectrum Disorder Market Size by Therapies in the United States
  • 15.2. EU-5 countries: Market Size and Outlook
  • 15.3. Germany Market Size
    • 15.3.1. Autism Spectrum Disorder Total Market Size in Germany
    • 15.3.2. Autism Spectrum Disorder Market Size by Therapies in Germany
  • 15.4. France Market Size
    • 15.4.1. Autism Spectrum Disorder Total Market Size in France
    • 15.4.2. Autism Spectrum Disorder Market Size by Therapies in France
  • 15.5. Italy Market Size
    • 15.5.1. Autism Spectrum Disorder Total Market Size in Italy
    • 15.5.2. Autism Spectrum Disorder Market Size by Therapies in Italy
  • 15.6. Spain Market Size
    • 15.6.1. Autism Spectrum Disorder Total Market Size in Spain
    • 15.6.2. Autism Spectrum Disorder Market Size by Therapies in Spain
  • 15.7. United Kingdom Market Size
    • 15.7.1. Autism Spectrum Disorder Total Market Size in the United Kingdom
    • 15.7.2. Autism Spectrum Disorder Market Size by Therapies in the United Kingdom
  • 15.8. Japan Market Outlook
    • 15.8.1. Japan Market Size
    • 15.8.2. Autism Spectrum Disorder Total Market Size in Japan
    • 15.8.3. Autism Spectrum Disorder Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Autism Spectrum Disorder

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

  • 20.1. Bibliography
  • 20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

The table of contents is not exhaustive; the final content may vary.

Product Code: DIMI0481

List of Tables

  • Table 1: 7MM Autism Spectrum Disorder Epidemiology (2020-2034)
  • Table 2: 7MM Autism Spectrum Disorder Diagnosed and Treatable Cases (2020-2034)
  • Table 3: Autism Spectrum Disorder Epidemiology in the United States (2020-2034)
  • Table 4: Autism Spectrum Disorder Diagnosed and Treatable Cases in the United States (2020-2034)
  • Table 5: Autism Spectrum Disorder Epidemiology in Germany (2020-2034)
  • Table 6: Autism Spectrum Disorder Diagnosed and Treatable Cases in Germany (2020-2034)
  • Table 7: Autism Spectrum Disorder Epidemiology in France (2020-2034)
  • Table 8: Autism Spectrum Disorder Diagnosed and Treatable Cases in France (2020-2034)
  • Table 9: Autism Spectrum Disorder Epidemiology in Italy (2020-2034)
  • Table 10: Autism Spectrum Disorder Diagnosed and Treatable Cases in Italy (2020-2034)
  • Table 11: Autism Spectrum Disorder Epidemiology in Spain (2020-2034)
  • Table 12: Autism Spectrum Disorder Diagnosed and Treatable Cases in Spain (2020-2034)
  • Table 13: Autism Spectrum Disorder Epidemiology in the UK (2020-2034)
  • Table 14: Autism Spectrum Disorder Diagnosed and Treatable Cases in the UK (2020-2034)
  • Table 15: Autism Spectrum Disorder Epidemiology in Japan (2020-2034)
  • Table 16: Autism Spectrum Disorder Diagnosed and Treatable Cases in Japan (2020-2034)
  • Table 17: Drug Name, Clinical Trials by Recruitment status
  • Table 18: Drug Name, Clinical Trials by Zone
  • Table 19: Total Seven Major Market Size in USD, Million (2020-2034)
  • Table 20: Region-wise Market Size in USD, Million (2020-2034)
  • Table 21: 7MM-Market Size by Therapy in USD, Million (2020-2034)
  • Table 22: United States Market Size in USD, Million (2020-2034)
  • Table 23: United States Market Size by Therapy in USD, Million (2020-2034)
  • Table 24: Germany Market Size in USD, Million (2020-2034)
  • Table 25: Germany Market Size by Therapy in USD, Million (2020-2034)
  • Table 26: France Market Size in USD, Million (2020-2034)
  • Table 27: France Market Size by Therapy in USD, Million (2020-2034)
  • Table 28: Italy Market Size in USD, Million (2020-2034)
  • Table 29: Italy Market Size by Therapy in USD, Million (2020-2034)
  • Table 30: Spain Market Size in USD, Million (2020-2034)
  • Table 31: Spain Market Size by Therapy in USD, Million (2020-2034)
  • Table 32: United Kingdom Market Size in USD, Million (2020-2034)
  • Table 33: United Kingdom Market Size by Therapy in USD, Million (2020-2034)
  • Table 34: Japan Market Size in USD, Million (2020-2034)
  • Table 35: Japan Market Size by Therapy in USD, Million (2020-2034)

The list of tables is not exhaustive; the final content may vary

List of Figures

  • Figure 1: 7MM Autism Spectrum Disorder Epidemiology (2020-2034)
  • Figure 2: 7MM Autism Spectrum Disorder Diagnosed and Treatable Cases (2020-2034)
  • Figure 3: Autism Spectrum Disorder Epidemiology in the United States (2020-2034)
  • Figure 4: Autism Spectrum Disorder Diagnosed and Treatable Cases in the United States (2020-2034)
  • Figure 5: Autism Spectrum Disorder Epidemiology in Germany (2020-2034)
  • Figure 6: Autism Spectrum Disorder Diagnosed and Treatable Cases in Germany (2020-2034)
  • Figure 7: Autism Spectrum Disorder Epidemiology in France (2020-2034)
  • Figure 8: Autism Spectrum Disorder Diagnosed and Treatable Cases in France (2020-2034)
  • Figure 9: Autism Spectrum Disorder Epidemiology in Italy (2020-2034)
  • Figure 10: Autism Spectrum Disorder Diagnosed and Treatable Cases in Italy (2020-2034)
  • Figure 11: Autism Spectrum Disorder Epidemiology in Spain (2020-2034)
  • Figure 12: Autism Spectrum Disorder Diagnosed and Treatable Cases in Spain (2020-2034)
  • Figure 13: Autism Spectrum Disorder Epidemiology in the UK (2020-2034)
  • Figure 14: Autism Spectrum Disorder Diagnosed and Treatable Cases in the UK (2020-2034)
  • Figure 15: Autism Spectrum Disorder Epidemiology in Japan (2020-2034)
  • Figure 16: Autism Spectrum Disorder Diagnosed and Treatable Cases in Japan (2020-2034)
  • Figure 17: Drug Name, Clinical Trials by Recruitment status
  • Figure 18: Drug Name, Clinical Trials by Zone
  • Figure 19: Total Seven Major Market Size in USD, Million (2020-2034)
  • Figure 20: Region-wise Market Size in USD, Million (2020-2034)
  • Figure 21: 7MM-Market Size by Therapy in USD, Million (2020-2034)
  • Figure 22: United States Market Size in USD, Million (2020-2034)
  • Figure 23: United States Market Size by Therapy in USD, Million (2020-2034)
  • Figure 24: Germany Market Size in USD, Million (2020-2034)
  • Figure 25: Germany Market Size by Therapy in USD, Million (2020-2034)
  • Figure 26: France Market Size in USD, Million (2020-2034)
  • Figure 27: France Market Size by Therapy in USD, Million (2020-2034)
  • Figure 28: Italy Market Size in USD, Million (2020-2034)
  • Figure 29: Italy Market Size by Therapy in USD, Million (2020-2034)
  • Figure 30: Spain Market Size in USD, Million (2020-2034)
  • Figure 31: Spain Market Size by Therapy in USD, Million (2020-2034)
  • Figure 32: United Kingdom Market Size in USD, Million (2020-2034)
  • Figure 33: United Kingdom Market Size by Therapy in USD, Million (2020-2034)
  • Figure 34: Japan Market Size in USD, Million (2020-2034)
  • Figure 35: Japan Market Size by Therapy in USD, Million (2020-2034)

The list of figures is not exhaustive; the final content may vary

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!